CN103819396B - A kind of 1-(3,5-dichloropyridine-4-base of chirality) synthetic method of-ethanol - Google Patents
A kind of 1-(3,5-dichloropyridine-4-base of chirality) synthetic method of-ethanol Download PDFInfo
- Publication number
- CN103819396B CN103819396B CN201410064211.1A CN201410064211A CN103819396B CN 103819396 B CN103819396 B CN 103819396B CN 201410064211 A CN201410064211 A CN 201410064211A CN 103819396 B CN103819396 B CN 103819396B
- Authority
- CN
- China
- Prior art keywords
- ethanol
- dichloropyridine
- base
- dichloropyridin
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种1-(3,5-二氯吡啶-4-基)-乙醇的不对称合成方法,包括以下步骤:(A)3,5-二氯吡啶(I)在胺基锂的作用下与乙醛反应生成(±)-1-(3,5-二氯吡啶-4-基)-乙醇(II);(B)(±)-1-(3,5-二氯吡啶-4-基)-乙醇(II)在氧化剂的作用下生成1-(3,5-二氯吡啶-4-基)-乙酮(III);(C)1-(3,5-二氯吡啶-4-基)-乙酮在手性配体存在下与硼烷试剂反应,制得单一光学异构体的1-(3,5-二氯吡啶-4-基)-乙醇(IV)。该法较传统手性柱分离(±)-1-(3,5-二氯吡啶-4-基)-乙醇相比,优点突出:(1)反应简单,易于操作,总收率高,光学纯度大于98%;(2)工业制备周期明显缩短,设备要求低;(3)制备成本低,是适合工业生产的方法。
The invention discloses an asymmetric synthesis method of 1-(3,5-dichloropyridine-4-yl)-ethanol, which comprises the following steps: (A) 3,5-dichloropyridine (I) in lithium amide Under the action of reaction with acetaldehyde to generate (±)-1-(3,5-dichloropyridin-4-yl)-ethanol (II); (B) (±)-1-(3,5-dichloropyridine -4-yl)-ethanol (II) generates 1-(3,5-dichloropyridin-4-yl)-ethanone (III) under the action of oxidant; (C) 1-(3,5-dichloro Reaction of pyridin-4-yl)-ethanone with borane reagent in the presence of chiral ligands to produce 1-(3,5-dichloropyridin-4-yl)-ethanol (IV) as a single optical isomer . Compared with traditional chiral column separation (±)-1-(3,5-dichloropyridin-4-yl)-ethanol, this method has outstanding advantages: (1) simple reaction, easy operation, high overall yield, optical The purity is greater than 98%; (2) The industrial preparation cycle is obviously shortened, and the equipment requirements are low; (3) The preparation cost is low, and it is a method suitable for industrial production.
Description
技术领域technical field
本发明属于医药中间体领域,涉及一种手性的1-(3,5-二氯吡啶-4-基)-乙醇合成方法及其应用。The invention belongs to the field of pharmaceutical intermediates, and relates to a chiral 1-(3,5-dichloropyridin-4-yl)-ethanol synthesis method and application thereof.
背景技术Background technique
成纤维细胞生长因子受体(FGFR)属于受体型蛋白酪氨酸激酶,该家族主要包括FGFR1、FGFR2、FGFR3和FGFR4四位成员。FGFR参与调节细胞增殖、凋亡、迁移、新生血管生成等多个过程。由于作用广泛,FGFR及其他RTK在正常情况下受到严格调控。在肿瘤中,如在乳腺癌、膀胱癌、前列腺癌等,FGFR激活突变或者配体/受体过表达导致其持续激活,不仅与肿瘤的发生、发展、不良预后等密切相关,并且在肿瘤新生血管生成、肿瘤的侵袭与转移等过程中也发挥重要作用。因此,FGFR被公认为是抗肿瘤重要靶点,FGFR小分子抑制剂的研发逐步受到越来越多的关注。FGFR抑制剂作为抗肿瘤化合物已有报道,如WO2002022598。其中LY2874455为一种特异性FGFRs的抑制剂,目前已经进入二期临床,前景十分看好。Fibroblast growth factor receptor (FGFR) belongs to the receptor-type protein tyrosine kinase family, which mainly includes four members: FGFR1, FGFR2, FGFR3 and FGFR4. FGFR is involved in the regulation of cell proliferation, apoptosis, migration, angiogenesis and many other processes. Because of their broad range of roles, FGFRs and other RTKs are normally tightly regulated. In tumors, such as breast cancer, bladder cancer, prostate cancer, etc., FGFR activating mutations or ligand/receptor overexpression lead to its continuous activation, which is not only closely related to the occurrence, development, and poor prognosis of tumors, but also in tumor neogenesis. It also plays an important role in angiogenesis, tumor invasion and metastasis. Therefore, FGFR is recognized as an important anti-tumor target, and the development of small molecule inhibitors of FGFR has gradually received more and more attention. FGFR inhibitors have been reported as anti-tumor compounds, such as WO2002022598. Among them, LY2874455 is a specific inhibitor of FGFRs, which has entered the second phase of clinical trials, and the prospect is very promising.
S-1-(3,5-二氯吡啶-4-基)乙醇是一种合成FGFR抑制剂LY2874455的重要中间体,而之前的文献报道采用HPLC手性柱分离消旋体得到单一的手性异构体S-1-(3,5-二氯吡啶-4-基)乙醇,并仅仅通过振动圆二色光谱和红外光谱进行光学异构体绝对构型的鉴定,如CN102421769A。其方法收率低,分离成本高,制备周期长,无法进行工业化生产。S-1-(3,5-dichloropyridin-4-yl)ethanol is an important intermediate for the synthesis of FGFR inhibitor LY2874455, and the previous literature reported that the racemate was separated by HPLC chiral column to obtain a single chiral Isomer S-1-(3,5-dichloropyridin-4-yl)ethanol, and the absolute configuration of optical isomers is identified only by vibrational circular dichroism and infrared spectroscopy, such as CN102421769A. The yield of the method is low, the separation cost is high, the preparation period is long, and industrial production cannot be carried out.
发明内容Contents of the invention
本发明的目的是提供一种高收率的不对称合成法,用于制备具有光学活性的1-(3,5-二氯吡啶-4-基)乙醇,该方法步骤短,制备简单,设备要求低,收率和光学纯度均很高,是适合工业生产的方法。The purpose of the present invention is to provide a high-yield asymmetric synthesis method for the preparation of optically active 1-(3,5-dichloropyridin-4-yl)ethanol, which has short steps, simple preparation, and equipment The requirement is low, the yield and optical purity are high, and it is a method suitable for industrial production.
本发明提供的一种手性的1-(3,5-二氯吡啶-4-基)-乙醇及磺酸酯的合成方法,其特征包括以下步骤:A chiral 1-(3,5-dichloropyridin-4-yl)-ethanol and sulfonate synthesis method provided by the present invention is characterized by the following steps:
a.3,5-二氯吡啶(I)在胺基锂的作用下与乙醛反应生成(±)-1-(3,5-二氯吡啶-4-基)-乙醇(II);a. 3,5-dichloropyridine (I) reacts with acetaldehyde under the action of lithium amide to generate (±)-1-(3,5-dichloropyridin-4-yl)-ethanol (II);
b.(±)-1-(3,5-二氯吡啶-4-基)-乙醇(II)在氧化剂的作用下生成1-(3,5-二氯吡啶-4-基)-乙酮(III);b. (±)-1-(3,5-dichloropyridin-4-yl)-ethanol (II) generates 1-(3,5-dichloropyridin-4-yl)-ethanone under the action of oxidant (III);
c.1-(3,5-二氯吡啶-4-基)-乙酮(III)在相应手性配体存在下与硼烷试剂反应,制得单一光学异构体的1-(3,5-二氯吡啶-4-基)-乙醇(IV);c.1-(3,5-dichloropyridin-4-yl)-ethanone (III) reacts with borane reagent in the presence of corresponding chiral ligands to obtain 1-(3, 5-dichloropyridin-4-yl)-ethanol (IV);
作为优选方式,所述步骤a中,使用的溶剂为四氢呋喃、乙醚、正己烷、环己烷中一种或多种;As a preferred mode, in the step a, the solvent used is one or more of tetrahydrofuran, ether, n-hexane, and cyclohexane;
作为优选方式,所述步骤a中,使用的胺基锂为二异丙基胺基锂;As a preferred mode, in the step a, the lithium amide used is lithium diisopropylamide;
作为优选方式,所述步骤a中,3,5-二氯吡啶与乙醛的摩尔比为:1:1~10;反应温度为:-78oC~0oC;反应时间:1~12小时;As a preferred mode, in the step a, the molar ratio of 3,5-dichloropyridine to acetaldehyde is: 1:1~10; the reaction temperature is: -78 o C ~ 0 o C; the reaction time: 1 ~ 12 Hour;
作为优选方式,所述步骤b中,所使用的溶剂为二氯甲烷或乙腈;氧化剂为吡啶氯铬酸鎓盐、吡啶重铬酸鎓盐、琼斯试剂(Jones)、戴斯-马丁试剂(Dess-Martin)中一种或多种;(±)-1-(3,5-二氯吡啶-4-基)-乙醇(II)与氧化剂的摩尔比为:1:1~5;反应温度为:-20oC~60oC;反应时间为:1~12小时;As a preferred mode, in the step b, the solvent used is dichloromethane or acetonitrile; the oxidizing agent is pyridinium chlorochromate, pyridinium dichromate, Jones reagent (Jones), Dess-Martin reagent (Dess -One or more of Martin); the molar ratio of (±)-1-(3,5-dichloropyridin-4-yl)-ethanol (II) to oxidant is: 1:1~5; the reaction temperature is : -20 o C~60 o C; Reaction time: 1~12 hours;
作为优选方式,所述步骤c中,所使用的溶剂为二氯甲烷、四氢呋喃、乙醚、二氧六环中一种或多种;手性配体选自:S-2-甲基-CBS-恶唑硼烷或者R-2-甲基-CBS-恶唑硼烷;硼烷试剂选自:硼烷二甲硫醚、硼烷四氢呋喃、硼烷吡啶中一种或多种;As a preferred mode, in the step c, the solvent used is one or more of dichloromethane, tetrahydrofuran, ether, and dioxane; the chiral ligand is selected from: S-2-methyl-CBS- Oxazolidine or R-2-methyl-CBS-oxazolidine; the borane reagent is selected from one or more of borane dimethyl sulfide, borane tetrahydrofuran, and borane pyridine;
作为优选方式,所述步骤c中,1-(3,5-二氯吡啶-4-基)-乙酮(III)、手性配体及硼烷试剂的摩尔比为:1:0.1-1:1-10,As a preferred mode, in the step c, the molar ratio of 1-(3,5-dichloropyridin-4-yl)-ethanone (III), chiral ligand and borane reagent is: 1:0.1-1 :1-10,
进一步优选,1-(3,5-二氯吡啶-4-基)-乙酮(III)、手性配体及硼烷试剂的摩尔比为:1:0.2:5;反应温度为-40oC~60oC,优选-10oC;反应时间为1~12小时;Further preferably, the molar ratio of 1-(3,5-dichloropyridin-4-yl)-ethanone (III), chiral ligand and borane reagent is: 1:0.2:5; the reaction temperature is -40 o C~60 o C, preferably -10 o C; the reaction time is 1~12 hours;
制备之初我们拟采用拆分的方法得到1-(3,5-二氯吡啶-4-基)-乙醇的单一异构体,并且尝试了多种手性拆分剂对其对映异构体进行手性拆分,但均未得到满意的结果。后来采用直接不对称还原其相应的酮的方法,并尝试多种手性配体及还原条件,最终以手性的2-甲基-CBS-恶唑硼烷得到最好的结果,ee>98%,并且两步反应总收率大于80%,明显优于直接拆分的方法,且操作简单易行,设备成本低,十分适合工业生产。At the beginning of the preparation, we planned to use the resolution method to obtain the single isomer of 1-(3,5-dichloropyridin-4-yl)-ethanol, and tried a variety of chiral resolving agents for its enantiomer The chiral resolution of the body was carried out, but no satisfactory results were obtained. Later, the method of direct asymmetric reduction of the corresponding ketone was adopted, and various chiral ligands and reduction conditions were tried, and finally the best result was obtained with chiral 2-methyl-CBS-oxazoboridine, ee>98 %, and the total yield of the two-step reaction is greater than 80%, which is obviously better than the direct resolution method, and the operation is simple and easy, and the equipment cost is low, which is very suitable for industrial production.
实施例Example
下面的对比例和实施例对本发明的技术方案做进一步说明,但是一定不认为这些对比例和实施例限制了本发明。The following comparative examples and examples further illustrate the technical solution of the present invention, but it must not be considered that these comparative examples and examples limit the present invention.
实施例1Example 1
1-(3,5-二氯吡啶-4-基)乙醇(II)的制备Preparation of 1-(3,5-dichloropyridin-4-yl)ethanol (II)
将二异丙基胺(DIPA,13.2ml,94.60mmol)溶于无水四氢呋喃(THF,50ml)中,-78℃下冷却,缓慢滴加正丁基锂(1.6M己烷溶液,50ml,81.08mmol),反应液逐渐浑浊,1h后滴毕,冷却20min后滴加3,5-二氯吡啶(I)(10g,67.57mmol)的THF(30ml)溶液,反应液为黄色浑浊状。滴加完成后冷却30min,滴加事先预冷的解聚乙醛(8.93g,11.4ml,135.14mmol)的THF(20ml)溶液,反应液变澄清。-78℃反应3h后,滴加饱和的氯化铵水溶液(50ml)停止反应,室温搅拌下过夜。用甲基叔丁基醚(MTBE,200ml)和饱和氯化铵溶液(500ml)稀释反应液,分出有机相,水层用MTBE洗涤3次,合并有机相用饱和食盐水洗涤,硫酸钠干燥,浓缩得红色油状物。通过硅胶柱层析(石油醚:乙酸乙酯=20:1)纯化,得白色固体8.50g,收率65%;mp:61-64℃;ESI-MS(m/z):214[M+Na]+ Diisopropylamine (DIPA, 13.2ml, 94.60mmol) was dissolved in anhydrous tetrahydrofuran (THF, 50ml), cooled at -78°C, and n-butyllithium (1.6M hexane solution, 50ml, 81.08 mmol), the reaction solution was gradually turbid, and after 1 hour, the drop was completed. After cooling for 20 minutes, a THF (30ml) solution of 3,5-dichloropyridine (I) (10g, 67.57mmol) was added dropwise, and the reaction solution was yellow and turbid. Cool for 30 minutes after the dropwise addition, and add dropwise a THF (20ml) solution of pre-cooled acetaldehyde (8.93g, 11.4ml, 135.14mmol), and the reaction solution becomes clear. After reacting at -78°C for 3 h, saturated ammonium chloride aqueous solution (50 ml) was added dropwise to stop the reaction, and stirred overnight at room temperature. Dilute the reaction solution with methyl tert-butyl ether (MTBE, 200ml) and saturated ammonium chloride solution (500ml), separate the organic phase, wash the aqueous layer 3 times with MTBE, wash the combined organic phase with saturated brine, and dry over sodium sulfate , concentrated red oil. Purified by silica gel column chromatography (petroleum ether: ethyl acetate = 20:1) to obtain 8.50 g of white solid, yield 65%; mp: 61-64 ° C; ESI-MS (m/z): 214 [M+ Na] +
实施例2Example 2
3,5-二氯-4-乙酰基吡啶(III)的制备Preparation of 3,5-dichloro-4-acetylpyridine (III)
将1-(3,5-二氯吡啶-4-基)乙醇(II)(6g,31.24mmol)溶于二氯甲烷(DCM,50ml),在10min内分批加入氯铬酸吡啶嗡盐(PCC,10.1g,46.86mmol),室温反应10h。过滤除去不溶物,滤渣用DCM洗涤3次,合并有机层,浓缩得粗品。通过硅胶柱层析(石油醚:乙酸乙酯=20:1)纯化,得无色浑浊油状物5.10g;收率85%;1H-NMR(CDCl3,400MHz)δ(ppm):2.58(s,3H),8.53(s,2H);ESI-MS(m/z):212[M+Na]+ 1-(3,5-Dichloropyridin-4-yl)ethanol (II) (6g, 31.24mmol) was dissolved in dichloromethane (DCM, 50ml), and pyridinium chlorochromate was added in portions within 10min ( PCC, 10.1g, 46.86mmol), react at room temperature for 10h. The insoluble matter was removed by filtration, the filter residue was washed 3 times with DCM, the organic layers were combined and concentrated to obtain a crude product. Purified by silica gel column chromatography (petroleum ether: ethyl acetate = 20:1) to obtain 5.10 g of a colorless turbid oil; 85% yield; 1 H-NMR (CDCl 3 , 400MHz) δ (ppm): 2.58 ( s,3H), 8.53(s,2H); ESI-MS(m/z):212[M+Na] +
实施例3Example 3
(R)-1-(3,5-二氯吡啶-4-基)乙醇(IV)(R)-1-(3,5-dichloropyridin-4-yl)ethanol (IV)
将(S)-2-甲基-CBS-恶唑硼烷(1M甲苯溶液,5.3ml,5.26mmol)与硼烷二甲硫醚络合物(BH3-DMS,10M二甲硫醚溶液,13.2ml,131.5mmol)溶于无水二氯甲烷(DCM,100ml)中,-10oC下搅拌10min,缓慢滴加3,5-二氯-4-乙酰基吡啶(III)(5g,26.3mmol)的DCM(30ml)溶液,滴毕,-10oC反应12h后,缓慢升至室温,缓慢滴入甲醇猝灭反应。滴毕,70oC回流3h。将反应液浓缩得粗品,通过硅胶柱层析(石油醚:乙酸乙酯=20:1)纯化,得无色油状物4.87g;收率96%,ee值98.14%(大赛璐ChiralpakAD-H,正己烷:异丙醇=95:5);[α]D=11.55(c=0.3292,MeOH);1H-NMR(CDCl3,400MHz)δ(ppm):1.56(d,J=6.8Hz,3H),3.56(brs,1H),5.47(q,J=6.8Hz,1H),8.34(s,2H);ESI-MS(m/z):214[M+Na]+ (S)-2-Methyl-CBS-oxazolidine (1M solution in toluene, 5.3ml, 5.26mmol) was mixed with borane dimethyl sulfide complex (BH3 - DMS, 10M solution in dimethyl sulfide, 13.2ml, 131.5mmol) was dissolved in anhydrous dichloromethane (DCM, 100ml), stirred at -10 o C for 10min, and slowly added dropwise 3,5-dichloro-4-acetylpyridine (III) (5g, 26.3 mmol) in DCM (30ml), dropwise, react at -10 o C for 12h, then slowly rise to room temperature, and slowly drop methanol to quench the reaction. After dropping, reflux at 70 o C for 3 hours. The reaction solution was concentrated to obtain a crude product, which was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 20:1) to obtain 4.87 g of a colorless oil; yield 96%, ee value 98.14% (Dacel ChiralpakAD-H, n-hexane:isopropanol=95:5); [α] D =11.55(c=0.3292,MeOH); 1 H-NMR(CDCl 3 ,400MHz)δ(ppm):1.56(d,J=6.8Hz, 3H),3.56(brs,1H),5.47(q,J=6.8Hz,1H),8.34(s,2H);ESI-MS(m/z):214[M+Na] +
实施例4Example 4
(R)-1-(3,5-二氯吡啶-4-基)乙基甲磺酸酯(V)(R)-1-(3,5-Dichloropyridin-4-yl)ethyl methanesulfonate (V)
将(R)-1-(3,5-二氯吡啶-4-基)乙醇(IV)(4.5g,23.43mmol)和三乙胺(8.54g,84.35mmol)溶于无水二氯甲烷(100ml)中,冰浴下搅拌滴加甲烷磺酰氯(3.22g,28.12mmol)。滴毕,室温反应,TLC检测反应至原料消失,将反应液倾入饱和碳酸氢钠溶液中,分出有机层,二氯甲烷返萃水层,合并有机层,饱和食盐水洗涤有机层3次后,无水硫酸钠干燥后减压蒸馏除去二氯甲烷通过硅胶柱层析(石油醚:乙酸乙酯=20:1)纯化,得纯白色晶体5.78g,收率91%。并通过单晶衍射确定了其绝对构型。1H-NMR(CDCl3,400MHz)δ(ppm):8.53(s,2H),6.37(q,J=6.8Hz,1H),2.98(s,3H),1.82(d,J=6.8Hz,3H);ESI-MS(m/z):292[M+Na]+ (R)-1-(3,5-Dichloropyridin-4-yl)ethanol (IV) (4.5 g, 23.43 mmol) and triethylamine (8.54 g, 84.35 mmol) were dissolved in anhydrous dichloromethane ( 100ml), methanesulfonyl chloride (3.22g, 28.12mmol) was added dropwise with stirring under ice bath. After dripping, react at room temperature, TLC detects the reaction until the raw materials disappear, pour the reaction solution into saturated sodium bicarbonate solution, separate the organic layer, extract the water layer back with dichloromethane, combine the organic layer, and wash the organic layer 3 times with saturated saline Finally, after drying over anhydrous sodium sulfate, dichloromethane was distilled off under reduced pressure and purified by silica gel column chromatography (petroleum ether: ethyl acetate = 20:1) to obtain 5.78 g of pure white crystals, with a yield of 91%. And its absolute configuration was confirmed by single crystal diffraction. 1 H-NMR(CDCl 3 ,400MHz)δ(ppm):8.53(s,2H),6.37(q,J=6.8Hz,1H),2.98(s,3H),1.82(d,J=6.8Hz, 3H); ESI-MS(m/z): 292[M+Na] +
实施例5Example 5
(S)-1-(3,5-二氯吡啶-4-基)乙醇(VI)(S)-1-(3,5-Dichloropyridin-4-yl)ethanol (VI)
将(R)-2-甲基-CBS-恶唑硼烷(1M甲苯溶液,3.2ml,3.15mmol)与硼烷二甲硫醚络合物(BH3-DMS,10M二甲硫醚溶液,7.9ml,78.9mmol)溶于无水二氯甲烷(DCM,75ml)中,-10oC下搅拌10min,缓慢滴加3,5-二氯-4-乙酰基吡啶(III)(3g,15.8mmol)的DCM(15ml)溶液,滴毕,-10oC反应10h后,缓慢升至室温,缓慢滴入甲醇猝灭反应。滴毕,70oC回流1.5h。将反应液浓缩得粗品,通过硅胶柱层析(石油醚:乙酸乙酯=20:1)纯化,得无色油状物2.83g;收率97%,ee值98.71%(大赛璐ChiralpakAD-H,正己烷:异丙醇=95:5);[α]D=-11.67(c=0.3314,MeOH);ESI-MS(m/z):214[M+Na]+ (R)-2-Methyl-CBS-oxazolidine (1M in toluene, 3.2ml, 3.15mmol) was mixed with borane dimethyl sulfide complex (BH3 - DMS, 10M dimethyl sulfide solution, 7.9ml, 78.9mmol) was dissolved in anhydrous dichloromethane (DCM, 75ml), stirred at -10 o C for 10min, and slowly added dropwise 3,5-dichloro-4-acetylpyridine (III) (3g, 15.8 mmol) in DCM (15ml), dropwise, react at -10 o C for 10h, then slowly rise to room temperature, and slowly drop methanol to quench the reaction. After dropping, reflux at 70 o C for 1.5h. The reaction solution was concentrated to obtain a crude product, which was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 20:1) to obtain 2.83 g of a colorless oil; yield 97%, ee value 98.71% (Dacel ChiralpakAD-H, n-hexane:isopropanol=95:5); [α] D =-11.67(c=0.3314,MeOH);ESI-MS(m/z):214[M+Na] +
实施例6(S)-1-(3,5-二氯吡啶-4-基)乙基甲磺酸酯(VII)Example 6 (S)-1-(3,5-dichloropyridin-4-yl)ethyl methanesulfonate (VII)
将(S)-1-(3,5-二氯吡啶-4-基)乙醇(VI)(1.8g,9.37mmol)和三乙胺(3.42g,50.61mmol)溶于无水二氯甲烷(50ml)中,冰浴下搅拌滴加甲烷磺酰氯(1.29g,11.25mmol)。滴毕,室温反应,TLC检测反应至原料消失,将反应液倾入饱和碳酸氢钠溶液中,分出有机层,二氯甲烷返萃水层,合并有机层,饱和食盐水洗涤有机层3次后,无水硫酸钠干燥后减压蒸馏除去二氯甲烷通过硅胶柱层析(石油醚:乙酸乙酯=20:1)纯化,得纯白色晶体2.15g,收率93%;ESI-MS(m/z):292[M+Na]+.(S)-1-(3,5-Dichloropyridin-4-yl)ethanol (VI) (1.8 g, 9.37 mmol) and triethylamine (3.42 g, 50.61 mmol) were dissolved in anhydrous dichloromethane ( 50ml), methanesulfonyl chloride (1.29g, 11.25mmol) was added dropwise with stirring under ice bath. After dripping, react at room temperature, TLC detects the reaction until the raw materials disappear, pour the reaction solution into saturated sodium bicarbonate solution, separate the organic layer, extract the water layer back with dichloromethane, combine the organic layer, and wash the organic layer 3 times with saturated saline Finally, after drying over anhydrous sodium sulfate, dichloromethane was distilled off under reduced pressure and purified by silica gel column chromatography (petroleum ether: ethyl acetate = 20:1) to obtain 2.15 g of pure white crystals, with a yield of 93%; ESI-MS ( m/z):292[M+Na] + .
图1(R)-1-(3,5-二氯吡啶-4-基)乙基甲磺酸酯单晶衍射图(见说明书附图)。Figure 1 (R)-1-(3,5-dichloropyridin-4-yl) ethyl methanesulfonate single crystal diffraction pattern (see the accompanying drawing).
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410064211.1A CN103819396B (en) | 2014-02-26 | 2014-02-26 | A kind of 1-(3,5-dichloropyridine-4-base of chirality) synthetic method of-ethanol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410064211.1A CN103819396B (en) | 2014-02-26 | 2014-02-26 | A kind of 1-(3,5-dichloropyridine-4-base of chirality) synthetic method of-ethanol |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103819396A CN103819396A (en) | 2014-05-28 |
CN103819396B true CN103819396B (en) | 2016-06-15 |
Family
ID=50754732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410064211.1A Expired - Fee Related CN103819396B (en) | 2014-02-26 | 2014-02-26 | A kind of 1-(3,5-dichloropyridine-4-base of chirality) synthetic method of-ethanol |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103819396B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111484393A (en) * | 2019-01-28 | 2020-08-04 | 上海茂晟康慧科技有限公司 | Preparation method of cis, cis-3, 5-dimethyl-1-cyclohexanol |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101274938A (en) * | 2007-03-27 | 2008-10-01 | 上海威智医药科技有限公司 | Preparation for (S) or (R)-2-methyl-CBS-chiral oxazaborolidine and toluene solution thereof |
WO2010129509A1 (en) * | 2009-05-07 | 2010-11-11 | Eli Lilly And Company | Vinyl indazolyl compounds |
CN102971306A (en) * | 2010-05-14 | 2013-03-13 | 医疗技术研究局 | Pyrazolopyridines as inhibitors of the kinase LRRK2 |
CN103153983A (en) * | 2010-10-05 | 2013-06-12 | 伊莱利利公司 | Crystalline (r) - (e) -2- (4- (2- (5- (1- (3, 5 -dichloropyridin-4 -yl) ethoxy) - 1H - indazol - 3 - yl) vinyl) -1 H- pyrazol- 1 -yl) ethanol and its use as FGFR inhibitor |
-
2014
- 2014-02-26 CN CN201410064211.1A patent/CN103819396B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101274938A (en) * | 2007-03-27 | 2008-10-01 | 上海威智医药科技有限公司 | Preparation for (S) or (R)-2-methyl-CBS-chiral oxazaborolidine and toluene solution thereof |
WO2010129509A1 (en) * | 2009-05-07 | 2010-11-11 | Eli Lilly And Company | Vinyl indazolyl compounds |
CN102971306A (en) * | 2010-05-14 | 2013-03-13 | 医疗技术研究局 | Pyrazolopyridines as inhibitors of the kinase LRRK2 |
CN103153983A (en) * | 2010-10-05 | 2013-06-12 | 伊莱利利公司 | Crystalline (r) - (e) -2- (4- (2- (5- (1- (3, 5 -dichloropyridin-4 -yl) ethoxy) - 1H - indazol - 3 - yl) vinyl) -1 H- pyrazol- 1 -yl) ethanol and its use as FGFR inhibitor |
Non-Patent Citations (1)
Title |
---|
Elias J.Corey等.Reduction of Carbonyl Compounds with Chiral Oxazaborolidine Catalysts: A New Paradigm for Enantioselective Catalysis and a Powerful New Synthetic Method.《Angew. Chem. Int. Ed.》.1998,第37卷第1987-2012页. * |
Also Published As
Publication number | Publication date |
---|---|
CN103819396A (en) | 2014-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Studies on Cu-catalyzed asymmetric alkynylation of tetrahydroisoquinoline derivatives | |
Li et al. | Direct synthesis of α-ketothioamides from aryl methyl ketones and amines via I2-promoted sp3 C–H functionalization | |
Rachwalski et al. | Aziridine ring-containing chiral ligands as highly efficient catalysts in asymmetric synthesis | |
Liu et al. | Asymmetric transfer hydrogenation of ketones with a polyethylene glycol bound Ru catalyst in water | |
Hao et al. | Unsymmetrical, oxazolinyl-containing achiral and chiral NCN pincer ligand precursors and their complexes with palladium (II) | |
CN103570482A (en) | Preparation method of 1,3-disubstituted allene compound | |
CN106986800B (en) | A kind of preparation method of β-carbonyl thioether | |
CN103819396B (en) | A kind of 1-(3,5-dichloropyridine-4-base of chirality) synthetic method of-ethanol | |
CN108864164B (en) | A kind of synthetic method of primary amine-directed 2-alkynyl indole compounds | |
CN104370976B (en) | Oxygen-containing substituents Er Mao Tie oxazoline phosphine ligands, it is prepared and the application in Asymmetrical annular-addition reaction | |
Hui et al. | Synthesis of new C2-symmetric bis (β-hydroxy amide) ligands and their applications in the enantioselective addition of alkynylzinc to aldehydes | |
CN102757390B (en) | Method for preparing 2-methoxy-4-diazanyl-5-fluoropyrimidine | |
Zhang et al. | Palladium-catalyzed Buchwald–Hartwig type amination of fluorous arylsulfonates | |
CN101967075B (en) | Method for synthesizing terminal alkyne compound by using 3-aryl-2,3-dibromopropionic acid | |
CN110240554B (en) | Alpha-thioether aryl acetonitrile compound and synthetic method thereof | |
Patel et al. | Synthesis of indenoquinolinone through aryne-mediated Pd (II)-catalysed remote C–H activation | |
CN105820174A (en) | Polysubstituted thienoindole derivative and preparation method thereof | |
CN104086488A (en) | Synthetic method of 2,4,6-tri-substituted pyrimidine compounds | |
CN109232501A (en) | A kind of preparation method of 4- p-methyl benzenesulfonic acid ester -2H- chromene | |
CN101497631A (en) | Oxazoline phosphine ligand and preparation thereof | |
CN104945434A (en) | (2-disubstituted phosphino-phenyl)-1-alkyl-indol-phosphine ligand and synthetic method and application thereof | |
CN105198690B (en) | The preparation method of the various positions substitution compound of fluorene class of halogen regulation and control | |
CN104926628B (en) | A kind of synthetic method of benzil analog derivative | |
KR101465844B1 (en) | Asymmetric Roskamp Reaction Catalyzed by an Oxazaborolidinium Ion | |
Bica et al. | Design, synthesis, and application of novel chiral ONN ligands for asymmetric alkylation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160615 Termination date: 20170226 |